SCHEMBL1269875

SCHEMBL1269875

CCCCCc1nc(NS(=O)(=O)c2ccc(Cl)cc2Cl)ncc1Sc1ccc(S(=O)(=O)N2CCCCC2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR Q13258 1/20 0.39
▸ PTGDR2 Q9Y5Y4 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ L3MBTL1 Q9Y468 4/20 0.39
▸ TSHR P16473 4/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ RECQL P46063 1/20 0.39
▸ MAPT P10636 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TP53 P04637 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ SLC40A1 Q9NP59 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ MERTK Q12866 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1269368 0.98 PTGDR (0.39) PTGDRPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL1269447 0.91 L3MBTL1 (0.41) ALDH1A1MEN1KMT2ALMNAL3MBTL1
SCHEMBL1268549 0.89 L3MBTL1 (0.42) ALDH1A1MEN1KMT2ALMNAL3MBTL1
SCHEMBL1269552 0.88 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ALMNAL3MBTL1
SCHEMBL1269882 0.87 PTGDR (0.42) PTGDRPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL1269558 0.86 PTGDR2 (0.42) PTGDRPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL1269394 0.86 ALDH1A1 (0.42) PTGDR2ALDH1A1MEN1KMT2ALMNA
SCHEMBL1269541 0.86 ALDH1A1 (0.42) ALDH1A1MEN1KMT2ALMNAL3MBTL1
SCHEMBL1268843 0.86 MAPT (0.41) PTGDRPTGDR2ALDH1A1MEN1KMT2A
SCHEMBL1268643 0.85 ALDH1A1 (0.41) PTGDRPTGDR2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
US-7893077-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2011-02-22 — — US disclosed
EP-1786782-B1 BISARYL-SULFONAMIDES AMGEN INC (US) 2010-03-31 — — EP disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-20090221584-A1 Bisaryl-sulfonamides AMGEN INC. 2009-09-03 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-7544702-B2 Bisaryl-sulfonamides AMGEN INC. (US) 2009-06-09 — — US disclosed
US-20060084802-A1 Bisaryl-sulfonamides AMGEN INC. 2006-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221584-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR 709/4885PTGDR2 649/4885ALDH1A1 2237/4885
US-20060084802-A1 Bisaryl-sulfonamides PPARD, PPARA, PPARG PTGDR 709/4885PTGDR2 649/4885ALDH1A1 2237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback